COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

被引:16
作者
Igarashi, Ataru [1 ]
Fukuchi, Yoshinosuke [2 ]
Hirata, Kazuto [3 ]
Ichinose, Masakazu [4 ]
Nagai, Atsushi [5 ]
Nishimura, Masaharu [6 ]
Yoshisue, Hajime [7 ]
Ohara, Kenichi [8 ]
Gruenberger, Jean-Bernard [9 ]
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan
[2] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
[3] Osaka City Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
[4] Tohoku Univ, Grad Sch Med, Dept Resp Med, Sendai, Miyagi, Japan
[5] Shin Yurigaoka Gen Hosp, Res Inst Resp Dis, Kawasaki, Kanagawa, Japan
[6] Hokkaido Univ, Fac Sch Med, Dept Pulm Med, Sapporo, Hokkaido, Japan
[7] Novartis Pharma KK, Med Div, Tokyo, Japan
[8] Novartis Pharma KK, Market Access Div, Tokyo, Japan
[9] Novartis Pharma AGAG, Market Access Div, Basel, Switzerland
关键词
health-realted quality of life; chart review; EQ-5D-5L questionnaire; health care resource utilization; productivity loss; work impairment WPAI-GH; OBSTRUCTIVE PULMONARY-DISEASE; PREVALENCE; PRODUCTIVITY; DETERMINANTS; POPULATION; TIOTROPIUM; SEVERITY; SAFETY; ASTHMA; IMPACT;
D O I
10.2147/COPD.S167476
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: COPD remains a major health problem in Japan. Patients with COPD experience a reduced quality of life (QoL) and have a higher chance of work impairment and productivity loss. However, there is a lack of data on the impact of COPD in terms of QoL and work activity impairment in Japan. This study assessed the socioeconomic burden of COPD in Japan and the impact it may have on the working age population. Patients and methods: This was a 2-year retrospective chart review in COPD patients aged >= 40 years, with at least one health care visit to clinic or hospital in the previous 12 months. Patients were required to have available medical charts for at least the previous 24 months. Symptoms were assessed using COPD assessment test score; EuroQoL Group 5 Dimension (EQ-5D-5L) and work productivity and activity impairment general health questionnaires were used to evaluate health-related QoL and work productivity, and health care resource utilization data were obtained from clinical charts. Results: In total, 71 patients aged <65 years, and 151 patients aged >= 65 years were included; the majority of patients had moderate or severe airflow limitation. Exacerbations (moderate or severe) were reported by similar to 35% of patients in both age groups; 52.1% and 62.9% of patients in the <65-year and >= 65-year age groups had COPD assessment test scores >= 10. EQ-5D-5L index scores in the <65-year and >= 65-year age groups were 0.79 and 0.77, respectively. Work productivity and activity impairment scores were higher in <65-year age group. Annual costs of health care resource use per patient in the <65-year and >= 65-year age groups were (sic)438,975 (US$4,389) and (sic)467,871 (US$4,678), respectively. Costs due to productivity loss were estimated to be (sic)5,287,024 (US$52,870) in the <65-year age group and (sic)3,018,974 (US$30,187) in the >= 65-year age group. Conclusion: COPD represents a significant socioeconomic burden in Japan. Patients with COPD report significant use of health care resources. Higher impact on work impairment and productivity loss was observed frequently in the working age population.
引用
收藏
页码:2629 / 2641
页数:13
相关论文
共 38 条
[1]  
[Anonymous], 2015, EQ 5D 5L USER GUIDE
[2]  
[Anonymous], 2014, GLOBAL INITIATIVE CH
[3]   International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750
[4]   The global impact of non-communicable diseases on macro-economic productivity: a systematic review [J].
Chaker, Layal ;
Falla, Abby ;
van der Lee, Sven J. ;
Muka, Taulant ;
Imo, David ;
Jaspers, Loes ;
Colpani, Veronica ;
Mendis, Shanthi ;
Chowdhury, Rajiv ;
Bramer, Wichor M. ;
Pazoki, Raha ;
Franco, Oscar H. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (05) :357-395
[5]   Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort [J].
Chubachi, Shotaro ;
Sato, Minako ;
Kameyama, Naofumi ;
Tsutsumi, Akihiro ;
Sasaki, Mamoru ;
Tateno, Hiroki ;
Nakamura, Hidetoshi ;
Asano, Koichiro ;
Betsuyaku, Tomoko .
RESPIRATORY MEDICINE, 2016, 117 :272-279
[6]   An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages [J].
de Marco, R ;
Accordini, S ;
Cerveri, I ;
Corsico, A ;
Sunyer, J ;
Neukirch, F ;
Künzli, N ;
Leynaert, B ;
Janson, C ;
Gislason, T ;
Vermeire, P ;
Svanes, C ;
Anto, JM ;
Burney, P .
THORAX, 2004, 59 (02) :120-125
[7]   COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population [J].
Fletcher, Monica J. ;
Upton, Jane ;
Taylor-Fishwick, Judith ;
Buist, Sonia A. ;
Jenkins, Christine ;
Hutton, John ;
Barnes, Neil ;
Van der Molen, Thys ;
Walsh, John W. ;
Jones, Paul ;
Walker, Samantha .
BMC PUBLIC HEALTH, 2011, 11
[8]   Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries [J].
Foo, Jason ;
Landis, Sarah H. ;
Maskell, Joe ;
Oh, Yeon-Mok ;
van der Molen, Thys ;
Han, MeiLan K. ;
Mannino, David M. ;
Ichinose, Masakazu ;
Punekar, Yogesh .
PLOS ONE, 2016, 11 (04)
[9]   Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC [J].
Fukahori, S. ;
Matsuse, H. ;
Takamura, N. ;
Hirose, H. ;
Tsuchida, T. ;
Kawano, T. ;
Fukushima, C. ;
Mizuta, Y. ;
Kohno, S. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (02) :269-274
[10]   COPD in Japan: The Nippon COPD Epidemiology Study [J].
Fukuchi, Y ;
Nishimura, M ;
Ichinose, M ;
Adachi, M ;
Nagai, A ;
Kuriyama, T ;
Takahashi, K ;
Nishimura, K ;
Ishioka, S ;
Aizawa, H ;
Zaher, C .
RESPIROLOGY, 2004, 9 (04) :458-465